Showing results (171-180 of 192) with videos related to
Sort By:
Pageof 20
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 2, 2024
Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child-Pugh A category: A multicenter studyYing Zhang, Kazushi Numata, Kento Imajo, et al.Digestive Diseases (Basel, Switzerland)|November 28, 2013
Hypovascular hepatic nodules showing hypointense on the hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: a nationwide retrospective study on their natural course and risk factorsTatsuo Inoue, Tomoko Hyodo, Takamichi Murakami, et al.Journal of Hepatology|May 29, 2021
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosisMasatoshi Kudo, Ana Matilla, Armando Santoro, et al.Journal of Gastroenterology|April 15, 2014
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled studyKiwamu Okita, Namiki Izumi, Osamu Matsui, et al.Diagnostics (Basel, Switzerland)|May 6, 2020
Consistency of Trans-Abdominal and Water-Immersion Ultrasound Images of Diseased Intestinal Segments in Crohn's DiseaseFeiqian Wang, Kazushi Numata, Hiromi Yonezawa, et al.Journal of Gastroenterology|September 12, 2014
Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trialKiwamu Okita, Namiki Izumi, Kenji Ikeda, et al.Hepatology (Baltimore, Md.)|April 16, 2016
Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinomaAnn-Lii Cheng, Sumitra Thongprasert, Ho Yeong Lim, et al.Hepatology International|July 4, 2024
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinomaMakoto Chuma, Haruki Uojima, Hidenori Toyoda, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 29, 2019
Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinomaMakoto Chuma, Hidenori Toyoda, Juntaro Matsuzaki, et al.Intestinal Research|July 15, 2024
Intestinal ultrasound for intestinal Behçet disease reflects endoscopic activity and histopathological findingsKatsuki Yaguchi, Reiko Kunisaki, Sho Sato, et al.Pageof 20